ZCMD Key Statistics, Chart & Performance
The current stock price of ZCMD is 0.483 USD. In the past month the price decreased by -19.37%. In the past year, price decreased by -72.08%.
ZCMD Latest News, Press Relases and Analysis
ZCMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| DUOL | DUOLINGO | 22.4 | 8.16B | ||
| BFAM | BRIGHT HORIZONS FAMILY SOLUT | 22.62 | 5.62B | ||
| LAUR | LAUREATE EDUCATION INC | 24.31 | 4.91B | ||
| GHC | GRAHAM HOLDINGS CO-CLASS B | 17.36 | 4.74B | ||
| LOPE | GRAND CANYON EDUCATION INC | 18.73 | 4.63B | ||
| ATGE | ADTALEM GLOBAL EDUCATION INC | 14.63 | 3.80B | ||
| MH | MCGRAW HILL INC | N/A | 3.12B | ||
| LRN | STRIDE INC | 9.97 | 2.83B | ||
| PRDO | PERDOCEO EDUCATION CORP | 11.55 | 1.87B | ||
| STRA | STRATEGIC EDUCATION INC | 13.74 | 1.85B | ||
| UTI | UNIVERSAL TECHNICAL INSTITUT | 21.79 | 1.35B | ||
| COUR | COURSERA INC | 16.86 | 1.18B |
Related stock screener links
About ZCMD
Company Profile
Zhongchao, Inc. is a holding company, which engages in the provision of healthcare information, education, and training services. The company is headquartered in Shanghai, Shanghai and currently employs 111 full-time employees. The company went IPO on 2020-02-19. The firm operates its businesses through two segments. MDMOOC Services segment engages in the provision of training and education services and assistance in patient-aid projects. Sales of Patented Drugs segment mainly engages in the sales of patented drugs. Under the MDMOOC brand, the Company offers a wide range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals as well as the public.
Company Info
ZHONGCHAO INC-CLASS A
841 Yan An Middle Road, Jing An District, Nanxi Creative Center, Suite 218
Shanghai SHANGHAI 200040 CN
CEO: Weiguang Yang
Employees: 111
Phone: 862132205987
ZHONGCHAO INC-CLASS A / ZCMD FAQ
What does ZHONGCHAO INC-CLASS A do?
Zhongchao, Inc. is a holding company, which engages in the provision of healthcare information, education, and training services. The company is headquartered in Shanghai, Shanghai and currently employs 111 full-time employees. The company went IPO on 2020-02-19. The firm operates its businesses through two segments. MDMOOC Services segment engages in the provision of training and education services and assistance in patient-aid projects. Sales of Patented Drugs segment mainly engages in the sales of patented drugs. Under the MDMOOC brand, the Company offers a wide range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals as well as the public.
What is the stock price of ZHONGCHAO INC-CLASS A today?
The current stock price of ZCMD is 0.483 USD. The price increased by 7.33% in the last trading session.
Does ZCMD stock pay dividends?
ZCMD does not pay a dividend.
What is the ChartMill rating of ZHONGCHAO INC-CLASS A stock?
ZCMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Would investing in ZHONGCHAO INC-CLASS A be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ZCMD.
Can you provide the market cap for ZHONGCHAO INC-CLASS A?
ZHONGCHAO INC-CLASS A (ZCMD) has a market capitalization of 14.85M USD. This makes ZCMD a Nano Cap stock.
ZCMD Technical Analysis
ZCMD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ZCMD. While ZCMD has a great health rating, there are worries on its profitability.
ZCMD Financial Highlights
Over the last trailing twelve months ZCMD reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS increased by 94.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.46% | ||
| ROE | -8.38% | ||
| Debt/Equity | 0 |